XM does not provide services to residents of the United States of America.

U.S. STOCKS Chemomab, Arcellx, Generac



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Chemomab, Arcellx, Generac</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

U.S. stock indexes were set to extend Tuesday's big rally after cooling producer prices supported views that the Federal Reserve has finished raising interest rates, while Target shares surged following an upbeat holiday-quarter forecast..N


At 9:12 ET, Dow e-minis 1YMc1 were up 0.13% at 34,931. S&P 500 e-minis ESc1 were up 0.21% at 4,520.5, while Nasdaq 100 e-minis NQc1 were up 0.44% at 15,949.5.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Vicarious Surgical <RBOT.N>, up 24.1%
** Target Corp <TGT.N>, up 13.6%
** MYT Netherlands Parent <MYTE.N>, up 12.7%

The top two NYSE percentage losers premarket .PRPL.NQ:
** James Hardie Industries <JHX.N>, down 12.7%
** Western Asset Inflation-Linked Income Fund <WIA.N>, down 11.5%

The top Nasdaq percentage gainers premarket .PRPG.O:
** Scisparc <SPRC.O>, up 70.6%

** Sirius XM Holdings Inc SIRI.O: up 16.8% premarket
BUZZ - Gains as Berkshire Hathaway takes stake in firm nL4N3CG2NK


** Spirit Airlines Inc SAVE.N: up 2.5% premarket
BUZZ - Up after extending revolving credit facility nL4N3CG2ST


** Canoo Inc GOEV.O: up 4.8% premarket
BUZZ - Rises on narrower loss forecast, spending outlook cut nL4N3CG39J


** Chemomab Therapeutics Ltd CMMB.O: up 54.1% premarket
BUZZ - Rises on FDA's 'fast track' tag for liver disorder treatment nL4N3CG32Z


** Livent Corp LTHM.N: up 2.1% premarket
BUZZ - Gets regulatory approvals for Allkem merger, shares rise nL4N3CG31T


** Advance Auto Parts Inc AAP.N: down 5.0% premarket
BUZZ - Falls on dour full-year forecast, quarterly loss nL4N36H3CI


** Arcellx Inc ACLX.O: up 13.8% premarket
BUZZ - Gains on expanded cancer treatments pact with Gilead unit nL4N3CG2VW


** Madrigal Pharmaceuticals Inc MDGL.O: up 2.1% premarket
BUZZ - TD Cowen says Madrigal allays competition fears from GLP-1 drugs nL4N3CG2ZO


** Catalent Inc CTLT.N: up 5.4% premarket
BUZZ - Rises on smaller-than-expected Q1 loss nL4N3CG2S8


** Dynatrace Inc DT.N: down 3.4% premarket
BUZZ - Down as Thoma Bravo to cut stake nL1N3CG17U


** Generac Holdings Inc GNRC.N: up 2.6% premarket
BUZZ - Rises as BofA upgrades to "neutral" nL4N3CG35D


** Goodyear Tire & Rubber Co GT.O: up 8.2% premarket
BUZZ - Gains on plans to cut costs nL4N3CG36D


** Target Corp TGT.N: up 13.6% premarket

** Walmart Inc WMT.N: up 0.6% premarket

** Macy's Inc M.N: up 2.5% premarket

** Kohl's Corp KSS.N: up 2.7% premarket
BUZZ - Shares surge on upbeat holiday-quarter profit forecast nL4N3CG2UJ


** Vertiv Holding Co VRT.N: up 1.4% premarket
BUZZ - Rises as Bofa lifts PT nL4N3CG38V

** SciSparc Ltd SPRC.O: up 70.6% premarket
BUZZ - Jumps on success of mid-stage trial for Alzheimer's therapy nL4N3CG3A3


** Chegg Inc CHGG.N: up 4.9% premarket
BUZZ - Gains on $150 mln accelerated share repurchase nL1N3CG1H9


(Compiled by Rajarshi Roy and Puyaan Singh)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.